Phillip Chan
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 3, 2023 | NIH | SBIR Phase I Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability | $7K | Cytosorbents Corp |
| Aug 29, 2022 | NIH | SBIR Phase I Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability | $282K | Cytosorbents Corp |
| Aug 10, 2020 | NIH | SBIR Phase II pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads | $992K | Cytosorbents Corp |
| Sep 23, 2019 | NIH | SBIR Phase II pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads | $983K | Cytosorbents Corp |
| Aug 16, 2018 | NIH | SBIR Phase II pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads | $996K | Cytosorbents Corp |
Peer ranks
Federal funding#584
Awards as PI#470
Patents#505
Companies
- Cytosorbents CorpLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.